MDxHealth SA
MDxHealth reported revenue of €4.16m for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 06 Jul 2026).
By total assets for 2025, MDxHealth ranks among the 20 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of MDxHealth shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +41 % Equity +79 % Total assets +28 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MDxHealth's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €4.16m | ||||
| Net result | −€4.14m | ||||
| Equity | €134.0m | ||||
| Cash | €20.3m | ||||
| EBITDA | −7,622 € | ||||
| Total assets | €159.3m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 30 May 2022
MDxHealth's financial analysis
- Solvency84.1%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MDxHealth
MDxHealth's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.292.440
- VAT number
- BE0479292440
- Peppol
- Registered · 0208:0479292440 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 15 Jan 2003
- Registered office
- 4040 Herstal
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
MDxHealth (SA) has been based in Herstal since 2003, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €4.16m, a net loss of €4.14m and equity of €134.0m. Its solvency stands at 84.1%, above the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MDxHealth
Companies in the same business, of comparable size and area, outside its group.
- AgomAb Therapeutics Technical testing and analysis Antwerp · balance sheet €251.3m
- Devgen Research and experimental development on natural sciences and engineering Ghent · balance sheet €130.9m
- Ncardia Holding Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €108.4m
- Ardena Holding Research and experimental development on natural sciences and engineering Ghent · balance sheet €87.1m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- iTeos Belgium Research and experimental development on natural sciences and engineering Charleroi · balance sheet €46.3m
- Fujirebio Europe Manufacture of other chemical products n.e.c. Ghent · balance sheet €81.8m
- Ogeda Research and experimental development on natural sciences and engineering Vilvoorde · balance sheet €53.5m
Frequently asked questions about MDxHealth
What is the revenue of MDxHealth?
According to the 2025 annual accounts filed with the NBB, the revenue of MDxHealth amounts to 4,157,415 €.
What is the VAT number of MDxHealth?
In Belgium, the VAT number is the company number prefixed with BE: BE0479292440 for MDxHealth, if the company is VAT-registered. Its company number (CBE) is 0479.292.440.
Where is the registered office of MDxHealth?
According to the CBE register, the registered office of MDxHealth is in 4040 Herstal.
What is the equity of MDxHealth?
At the close of the 2025 financial year, the equity of MDxHealth amounts to 133,987,404 €, a solvency of 84.1% of total assets.
Who manages MDxHealth?
The register lists 10 active mandates at MDxHealth. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is MDxHealth within its sector?
By total assets for 2025, MDxHealth ranks among the 20 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of MDxHealth
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →